Trial site

P-One Clinic

Hachiōji, 192-0071, JapanNot linked to an institution yet

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions: Alzheimer disease4 trials
Obesity2 trials
Atopic dermatitis (eczema)1 trial
Fatty liver disease (MASLD/MASH)1 trial
High blood pressure1 trial
Parkinson disease1 trial
Type 2 diabetes1 trial
Phase: Phase 16 trials
Phase 34 trials
Status: Completed4 trials
Active, not recruiting3 trials
Recruiting2 trials
Terminated1 trial
Lead sponsor: Eli Lilly and Company10 trials

Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
NCT07602582· Phase 3· Eli Lilly and Company· Source
Contact: Kenichi Furihata (principal investigator)
Recruiting
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
NCT06809400· Phase 1· Eli Lilly and Company· Source
Contact: Kenichi Furihata (principal investigator)
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
NCT06653153· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
NCT05026866· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
NCT04437511· Phase 3· Eli Lilly and Company· Source

How many trials recruit for the same indication here at once. A count, not a rating.

Site data: ClinicalTrials.govUpdated 12 Nov 2026